Hematologic complications after kidney and pancreas transplant in a patient with chronic myeloid leukemia
Cleve Clin J Med
.
2024 Mar 1;91(3):183-190.
doi: 10.3949/ccjm.91a.23042.
Authors
Binoy Yohannan
1
,
Allen Omo-Ogboi
2
,
Johncy John Kachira
3
,
Harinder Juneja
4
Affiliations
1
Division of Hematology/Oncology, McGovern Medical School, The University of Texas Health Science Center, Houston, TX binoyyohannan87@gmail.com.
2
Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, TX.
3
Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
4
Division of Hematology/Oncology, McGovern Medical School, The University of Texas Health Science Center, Houston, TX.
PMID:
38429002
DOI:
10.3949/ccjm.91a.23042
No abstract available
MeSH terms
Humans
Kidney
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Pancreas
Pancreas Transplantation* / adverse effects